Table: begin end state 1 22 cytoplasmic 23 46 transmembrane 47 57 non-cytoplasmic 58 80 transmembrane 81 89 cytoplasmic 90 110 transmembrane 111 115 non-cytoplasmic 116 136 transmembrane 137 147 cytoplasmic 148 172 transmembrane 173 178 non-cytoplasmic 179 197 transmembrane 198 266 cytoplasmic 267 289 transmembrane 290 300 non-cytoplasmic 301 322 transmembrane 323 328 cytoplasmic 329 349 transmembrane 350 356 non-cytoplasmic 357 378 transmembrane 379 397 cytoplasmic 398 417 transmembrane 418 422 non-cytoplasmic 423 442 transmembrane 443 459 cytoplasmic
Input: >AO353_06120 FitnessBrowser__pseudo3_N2E3:AO353_06120 METQGYSAAERLERLPISGYHRIIFIIIALAFFFDSMDLAMMTFLLGSIKAEFALSTAQA GLLASSSFFGMVLGASLSGMLADRFGRKPVFQWSIVLWGIASYLCSTAQSVETLTLFRVL LGIGMGMEFPIAQSMLSELIPAKRRGRYIALMDGFWPLGFVAAGVLSYFLLPLVGWRDIF LVLAVPAVFVLAIRFFIPESPRWLEQAGHHAAADKVLLRIEDKVRTSLGSADLPEPIRLP RIESRPGHFLSALNEIWSPLYRQRTMMIWSVWFFALLGFYGLTSWLSALLQQSGFAVTQS VYYTVLISLGGIPGFLMAAWLVERWGRKPVCIITLLGGGVMAFLYGQSAVFGGNVSLLIS SGLLMQFFLFGMWAVLYTYTPELYPTSARATGSGFASAIGRVGSLLGPLVTGLVFPITGQ GGVFALGAMCFAIAAGVVWLFGMETQGKTLEELSEVVAG
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server